Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide Krka

lenalidomide hydrochloride monohydrate · Krka, d.d., Novo mesto
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenalidomide Krka, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: EMA Authorised: Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) (lenalidomide hydrochloride monohydrate) — Krka, d.d., Novo mesto

See pricing